Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May;72(2):358-374.
doi: 10.1007/s12020-020-02436-9. Epub 2020 Aug 5.

Effects of endocrine disruptors on fetal testis development, male puberty, and transition age

Affiliations
Review

Effects of endocrine disruptors on fetal testis development, male puberty, and transition age

Francesco Cargnelutti et al. Endocrine. 2021 May.

Erratum in

Abstract

Purpose: Endocrine disruptors (EDs) are exogenous substances able to impair endocrine system; consequently, they may cause numerous adverse effects. Over the last years, particular focus has been given to their harmful effects on reproductive system, but very little is known, especially in males. The aim of this review is to discuss the detrimental effects of EDs exposure on fetal testis development, male puberty, and transition age.

Methods: A search for the existing literature focusing on the impact of EDs on fetal testis development, male puberty, andrological parameters (anogenital distance, penile length, and testicular volume), and testicular cancer with particular regard to pubertal age provided the most current information available for this review. Human evidence-based reports were given priority over animal and in vitro experimental results. Given the paucity of available articles on this subject, all resources were given careful consideration.

Results: Information about the consequences associated with EDs exposure in the current literature is limited and often conflicting, due to the scarcity of human studies and their heterogeneity.

Conclusions: We conclude that current evidence does not clarify the impact of EDs on human male reproductive health, although severe harmful effects had been reported in animals. Despite controversial results, overall conclusion points toward a positive association between exposure to EDs and reproductive system damage. Further long-term studies performed on wide number of subjects are necessary in order to identify damaging compounds and remove them from the environment.

Keywords: Endocrine disruptors; Male reproductive health; Testicular cancer; Testicular function.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Endocrine disruptors mechanisms of endogenous hormone imbalance and the adverse consequences on male puberty, genital development, and andrological health

References

    1. Hauser R, Skakkebaek NE, Hass U, et al. Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union. J. Clin. Endocrinol. Metab. 2015;100(4):1267–1277. doi: 10.1210/jc.2014-4325. - DOI - PMC - PubMed
    1. Sifakis S, Androutsopoulos VP, Tsatsakis AM, Spandidos DA. Human exposure to endocrine disrupting chemicals: effects on the male and female reproductive systems. Environ. Toxicol. Pharmacol. 2017;51:56–70. doi: 10.1016/j.etap.2017.02.024. - DOI - PubMed
    1. Soubry A, Schildkraut JM, Murtha A, et al. Paternal obesity is associated with IGF2 hypomethylation in newborns: results from a Newborn Epigenetics Study (NEST) cohort. BMC Med. 2013;11:29. doi: 10.1186/1741-7015-11-29. - DOI - PMC - PubMed
    1. Soubry A, Murphy SK, Wang F, et al. Newborns of obese parents have altered DNA methylation patterns at imprinted genes. Int. J. Obes. 2015;39(4):650–657. doi: 10.1038/ijo.2013.193. - DOI - PMC - PubMed
    1. Katsikantami I, Sifakis S, Tzatzarakis MN, et al. A global assessment of phthalates burden and related links to health effects. Environ. Int. 2016;97:212–236. doi: 10.1016/j.envint.2016.09.013. - DOI - PubMed

Publication types

Substances